We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEFT icon
701
Euronet Worldwide
EEFT
$3.01B
– –
-4,137
Closed -$328K
EGO icon
702
Eldorado Gold
EGO
$8.48B
– –
-12,702
Closed -$113K
EHAB
703
DELISTED
Enhabit
EHAB
– –
-12,385
Closed -$139K
EHC icon
704
Encompass Health
EHC
$11.3B
– –
-3,593
Closed -$241K
EIX icon
705
Edison International
EIX
$30.3B
– –
-5,341
Closed -$338K
ELAN icon
706
Elanco Animal Health
ELAN
$12.7B
– –
-10,918
Closed -$123K
ELME
707
Elme Communities
ELME
$144M
– –
-26,101
Closed -$356K
EMN icon
708
Eastman Chemical
EMN
$7.74B
– –
-3,532
Closed -$271K
ENOV icon
709
Enovis
ENOV
$1.63B
– –
-6,959
Closed -$367K
EOLS icon
710
Evolus
EOLS
$407M
– –
-10,475
Closed -$95.7K
EOG icon
711
EOG Resources
EOG
$74.7B
– –
-2,495
Closed -$316K
ES icon
712
Eversource Energy
ES
$28.1B
– –
-3,806
Closed -$221K
ESAB icon
713
ESAB
ESAB
$5.49B
– –
-5,107
Closed -$359K
ESNT icon
714
Essent Group
ESNT
$6.12B
– –
-6,684
Closed -$316K
EVRG icon
715
Evergy
EVRG
$19.8B
– –
-13,108
Closed -$665K
EXLS icon
716
EXL Service
EXLS
$4.36B
– –
-14,869
Closed -$417K
EXP icon
717
Eagle Materials
EXP
$6.69B
– –
-1,652
Closed -$275K
EXPO icon
718
Exponent
EXPO
$3.04B
– –
-3,479
Closed -$298K
FATE icon
719
Fate Therapeutics
FATE
$283M
– –
-163,617
Closed -$347K
FELE icon
720
Franklin Electric
FELE
$4.66B
– –
-4,712
Closed -$420K
FIX icon
721
Comfort Systems
FIX
$60.9B
– –
-3,413
Closed -$582K
FOLD
722
DELISTED
Amicus Therapeutics
FOLD
– –
-20,280
Closed -$247K
FOUR icon
723
Shift4
FOUR
$3.96B
– –
-4,544
Closed -$252K
GD icon
724
General Dynamics
GD
$105B
– –
-2,514
Closed -$556K
GGG icon
725
Graco
GGG
$13B
– –
-10,034
Closed -$731K
27 28
29
30 31

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.